ALINA GERASYMOVA: Open Payments
NPI 1205347994 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 39 payments from 16 companies in 2025. Trend: 2023 $522 · 2024 $1,315 · 2025 $1,266
Food & beverage: $1,266
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $317 |
| ABBVIE INC. | 9 | $254 |
| GENZYME CORPORATION | 3 | $135 |
| REVANCE THERAPEUTICS, INC. | 1 | $107 |
| PFIZER INC. | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| UCB, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, DAXXIFY, CIBINQO, COSENTYX, Zoryve, Bimzelx.
Industry payments across MD — which companies pay providers there.
